| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,027 | 15,558 | 15,765 | 16,203 | | Cost of Revenue | 5,221 | 5,322 | 6,528 | 5,380 | | | Gross Profit | 10,806 | 10,236 | 9,237 | 10,823 | | | Operating Expenses | | Research Development | 1,265 | 1,237 | 1,538 | 1,183 | | Selling General and Administrative | 8,156 | 8,573 | 11,700 | 9,562 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,385 | 426 | (4,001) | 78 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (59) | 5 | 21 | 140 | | Earnings Before Interest And Taxes | 1,326 | 431 | (3,980) | 218 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,326 | 431 | (3,980) | 218 | | Income Tax Expense | (10) | 17 | (68) | 38 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,336 | 414 | (3,912) | 180 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,336 | 414 | (3,912) | 180 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,336 | $414 | ($3,912) | $180 |
|
0.51% Nasdaq 
Income Statement
